לשכת המדען הראשי | |
Organization overview | |
---|---|
Formed | 1969 | (as the Office of the Chief Scientist)
Preceding Organization |
|
Headquarters | Jerusalem, Israel |
Organization executive |
|
Parent Organization | Ministry of Economy |
Website | www |
The Israel Innovation Authority previously known as the Office of the Chief Scientist (Hebrew: לשכת המדען הראשי, translit. lishkat Ha-madʿan ha-rashi) of Israel’s Ministry of Economy is the support arm of the Israeli government, charged with fostering the development of industrial R&D within the State of Israel. The mission of the Authority has been defined through the country's "Law for the Encouragement of Industrial Research and Development—1984" (The R&D Law) and its operations are facilitated through Israel's R&D Fund, as well as a variety of international programs, agreements and collaborations. Its mission is to assist the advancement of Israel's knowledge-based science and technology industries in order to encourage innovation and entrepreneurship while stimulating economic growth.
Legal aspects of agreements which may include R&D funding, as well as royalties, are governed under the Regulatory Framework of the Authority.
The Office of the Chief Scientist was established in 1974. It was renamed the Israel Innovation Authority in 2016. The main aim of the department is to increase economic empowerment within the civilian sector of the Israeli economy. Main activities include the funding of research and policy-making within its sphere of influence. The development and prominence of the OCS was further strengthened by the development of the Venture Capital industry within Israel in the 1990s.
The Authority manages three distinct frameworks. The R&D Fund (Tmura), an Incubator Program and the Magnet Program. The OCS is responsible for Iserd management within the European Union Framework as well as Matimop, which governs international agreements partnerships in the USA, Canada and the rest of the world. The Magnet Program was established in 1994, and manages the partnership between academic and commercial R&D programs. Significant activities include facilitation of the transfer of knowledge between academia and commercial R&D companies. Under the auspices of the Magnet Program, the NOFAR program was established to provide support and funding in the field of biotechnology, nanotechnology and development of medical equipment.